Is N-methylacetazolamide a possible new therapy against ischemia-reperfusion injury?
The increase of intracellular Ca2+ concentration, produced principally by its influx through the L-type Ca2+ channels, is one of the major contributors to the ischemia-reperfusion injury. The inhibition of those channels in different experimental models was effective to ameliorate the post-ischemic...
Saved in:
Main Authors: | Alejandro Ciocci Pardo (Author), Leandro A. Díaz Zegarra (Author), Luisa F. González Arbeláez (Author), Ernesto A. Aiello (Author), Susana M. Mosca (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
c-Jun N-Terminal Kinases (JNKs) in Myocardial and Cerebral Ischemia/Reperfusion Injury
by: Maria Shvedova, et al.
Published: (2018) -
Quercetin Liposomal Nanoformulation for Ischemia and Reperfusion Injury Treatment
by: Margarida Ferreira-Silva, et al.
Published: (2022) -
Role of curcumin in ischemia and reperfusion injury
by: Minglei Bi, et al.
Published: (2023) -
N-methyladenosine demethylases Alkbh5/Fto regulate cerebral ischemia-reperfusion injury
by: Kaiwei Xu, et al.
Published: (2020) -
Angiotensin antagonists and renal ischemia/reperfusion: Possible modulation by l-carnitine
by: Maha A. Rabie, et al.
Published: (2012)